RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 18 - per page Next page
Order by
ORS effervescent tablet (Oral Rehydration Salts)
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Iron supplement chewable tablets
Innovative chewable tablets iron based More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation and rapid reconstitution of biopharmaceuticals
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Transferrin-Conjugated Nanoparticles (TID - 95)
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
Gadomni(Gadopentetate dimeglumine)
MRI contast medium More
MASH - Multiple Angle Switched HIFU (High Intensity Focused Ultrasound) for precise and localized drug delivery (08-25)
Precise and focused control of temperature mediated therapy and “triggering” deliverables in situ. More
Preparation Methods for Biodegradable Micro-Particles Containing Polypeptide Drugs – non-organic suspension – encapsulation techniques (08-34)
drug delivery - a novel and effective method for the microencapsulation of small peptides that allows their use and controlled release over a time frame of several months. More
Displaying 1..10 of 18 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Advances in the Transdermal Drug Delivery Market
Oct 2010 - 97 pages - $3,835
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Jun 2009 - 118 pages - $1,040
Who's Developing What in Drug Delivery 2009
Nov 2009 - 830 pages - $1,040
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Aveva Drug Delivery Systems-Therapeutic Competitors Report
Nov 2010 - 97 pages - $600
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Dec 2009 - 84 pages - $7,600
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech
Nov 2010 - 428 pages - $2,695
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us